Related Experiment Videos
Symptomatic and asymptomatic visual loss in patients taking vigabatrin
H Daneshvar1, L Racette, S G Coupland
1The University of Ottawa Eye Institute, Ontario, Canada.
Ophthalmology
|September 15, 1999
Summary
Long-term vigabatrin use may cause more frequent visual field constriction, often without symptoms. Regular eye exams are crucial for patients on this antiepileptic medication.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Vigabatrin is an antiepileptic drug used for long-term treatment.
- Visual field loss is a potential side effect that requires investigation.
Observation:
- A case series studied 12 patients with peripheral visual field constriction on vigabatrin.
- Patients underwent detailed perimetry and electrophysiologic testing.
Findings:
- Nine of 12 patients showed bilateral visual field constriction on central 30-2 perimetry.
- Electrophysiologic tests revealed abnormalities in ERG, EOG, and VEP in several patients.
- Asymptomatic visual field loss was common, suggesting a higher incidence than previously reported.
Implications:
- Vigabatrin-induced visual field constriction may be more prevalent and often asymptomatic.
- Muller cell dysfunction in the peripheral retina is a potential mechanism.
- Regular peripheral visual field examinations are recommended for patients on vigabatrin.